Skip to main content

Day: March 6, 2024

JD.com Announces Fourth Quarter and Full Year 2023 Results, Annual Dividend and Share Repurchase Program

BEIJING, March 06, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced its unaudited financial results for the three months and the full year ended December 31, 2023 and an annual cash dividend for the year ended December 31, 2023. The company also announced the adoption of a new share repurchase program under which the company may repurchase up to US$3.0 billion worth of its shares (including ADSs) over the next 36 months through March 2027. Fourth Quarter and Full Year 2023 HighlightsNet revenues for the fourth quarter of 2023 were RMB306.1 billion (US$143.1 billion), an increase of 3.6% from the fourth quarter of 2022. Net revenues for the full year of 2023 were RMB1,084.7 billion (US$152.8 billion),...

Continue reading

SalMar – Presentation North Atlantic Seafood Forum

Today at North Atlantic Seafood Forum SalMar is launching an ambitious innovation and R&D initiative, Salmon Living Lab. Attached you will find a copy of the presentation presented by the CEO of SalMar Frode Arntsen. Please see the press release available from SalMars website and www.salmonlivinglab.no for more information about Salmon Living Lab. For more information please contact: Håkon Husby, Head of IR SalMar Tel: +47 936 30 449 Email: hakon.husby@salmar.no About SalMar SalMar is one of the world’s largest and most efficient producers of salmon. The Group has farming operations in Central Norway, Northern Norway and Iceland, as well as substantial harvesting and secondary processing operations. In addition, the company is operating within offshore aquaculture through the company SalMar Aker Ocean and SalMar owns 50% of...

Continue reading

Dassault Aviation: Total number of shares and voting rights – 29 02 24

DASSAULT AVIATION French corporation (société anonyme) with a share capital of 64,641,892.80 euros Headquarters: 9, Rond-Point des Champs-Elysées Marcel Dassault – 75008 PARIS RCS PARIS 712 042 456 Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code (Code de commerce) and article 223-16 of the General Regulations (Règlement Général) of the French Market Authority (Autorité des Marchés Financiers)DateTotal number of sharesTotal number of voting rights02/29/2024 80,802,366Theoretical voting rights: 132,899,470 Exercisable voting rights: 130,806,850AttachmentTotal number of shares and voting rights – 29 02 24

Continue reading

Result of the auction of 2.25 per cent DGB 2026 and 2.25 per cent DGB 2033G

Bids, sales, cut-off price, pro rata and yield are presented in the table below:           ISIN Bid mill. DKK (nominal) Sale mill.DKK (nominal) Cut-off price Pro rata Yield9924888 DGB 2.25% 15/11/2026 2,850 600 99.20 100 % 2.56 % p.a.9924615 DGB 2.25% 15/11/2033G 3,955 2,605 98.73 100 % 2.40 % p.a.Total 6,805 3,205      Settlement: 08 March 2024

Continue reading

Allot Wins Prestigious 2024 Frost & Sullivan Customer Value Leadership Award for CSP Security

Allot is recognized for its valuable contribution to the consumer and small business security industry.Frost & Sullivan Best Practices AwardGlobal CSP Security for SOHO and Consumers Customer Value Leadership AwardHod Hasharon, Israel, March 06, 2024 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and converged network-native security solutions for communication service providers and enterprises, today announced that Frost & Sullivan has recognized Allot as the 2024 Customer Value Leader in the SOHO and consumer space for its contribution to CSP security. Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership,...

Continue reading

Intermediate Capital Group PLC Board Update

Intermediate Capital Group PLC (“the Company”) 6 March 2024 The Board of Intermediate Capital Group PLC announces that as part of our long term succession planning, Michael (Rusty) Nelligan, Non-Executive Director of the Company, will retire from the Board with effect from 31 March 2024. Rusty has served on the Board since 2016. The Board wishes to express its gratitude to Rusty for his highly effective and wide-ranging contribution to the Board and its Committees as a Non-Executive Director and as Chair of the Audit Committee between September 2016 and June 2022. This announcement is made pursuant to LR 9.6.14 of the Listing Rules of the Financial Conduct Authority. Contacts: Chris Hunt Investor Relations, Intermediate Capital Group PLC+44 (0) 20 3545 2020 Fiona Laffan Corporate Affairs, Intermediate Capital Group PLC+44 (0) 20 3545 1510 Andrew...

Continue reading

The Atos, Open and Sopra Steria Consortium selected by UGAP to support the digital transformation of public services

Press release The Atos, Open and Sopra Steria Consortium selected by UGAP to support the digital transformation of public services The Consortium’s project management assistance and third-party application maintenance services fulfill the complete requirements for customers of France’s leading public procurement agency. Paris, France – March 6, 2024 – The digital services companies Atos, Open and Sopra Steria, in a Consortium headed by Atos, today announce that they have been selected by the Union des Groupements d’Achats Publics (UGAP) to supply project management assistance (AMOE) and third-party application maintenance (TMA) services, in response to UGAP’s new IT Intellectual Services (PII) contract. The Consortium, whose previous co-owners were Atos and Open, has been strengthened by the addition of Sopra Steria...

Continue reading

Health technology leader Philips recognized as Clarivate Top 100 Global Innovator

Azurion neuro biplanePhilips BlueSeal MRI MagnetPhilips HealthSuite ImagingEPIQ Elite ultrasound systemMarch 6, 2024 Company’s innovative products and solutions improved the lives of 1.9 billion people in 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been included in the 2024 Clarivate Top 100 Global Innovator™ list. Philips’ global R&D programs and collaborations aim to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Together with healthcare providers and other ecosystem partners, Philips co-creates innovations that increase access to healthcare globally and create sustainable and resilient healthcare models. For...

Continue reading

Ontex listed on the 2023 CDP Supplier Engagement Leaderboard, recognizing its climate action efforts across the value chain

Aalst, Belgium, March 6, 2024 – Ontex (Euronext: ONTEX) is proud to have been recognized by CDP for its climate actions in partnership with its suppliers, specifically aimed at reducing its scope 3 emissions. Ontex is among the highest-rated companies that are celebrated in the 2023 Supplier Engagement Rating Leaderboard, which evaluates corporate supply chain engagement on climate issues. Marco Querzoli, Chief Supply Chain Officer said: “Following Ontex’s CDP A- rating for leadership in climate change in February, being added to the Supplier Engagement Leaderboard, is a second substantial recognition related to our sustainability achievements in 2023. To everyone at Ontex, this is simply a confirmation of the ongoing commitment to partnering with stakeholders across the value chain, and to delivering the very best value and quality for...

Continue reading

Karolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PD

STOCKHOLM, SWEDEN – March 6, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition will present recent nonclinical data elucidating golexanolone’s mode-of-action in Parkinson’s disease at the 18th International Conference on Alzheimer’s and Parkinson’s Diseases 2024 in Lisbon, Portugal, during March 5-9. Parkinson’s disease is a progressive neurodegenerative disease hallmarked by motor symptoms and disrupted cognitive functions as well as mental health. The study that will be presented at the AD/PD conference shows that golexanolone improves both motor symptoms and non-motor symptoms, including fatigue, anxiety and depression. Further, golexanolone was found to partially inhibit the decrease of enzyme tyrosine hydroxylase and prevent the increase of neurotoxic protein alpha-synuclein,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.